IL56577A - Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones - Google Patents

Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones

Info

Publication number
IL56577A
IL56577A IL56577A IL5657779A IL56577A IL 56577 A IL56577 A IL 56577A IL 56577 A IL56577 A IL 56577A IL 5657779 A IL5657779 A IL 5657779A IL 56577 A IL56577 A IL 56577A
Authority
IL
Israel
Prior art keywords
pyrrolidinones
substituted
certain
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IL56577A
Other languages
English (en)
Other versions
IL56577A0 (en
Original Assignee
Sparamedica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sparamedica Ag filed Critical Sparamedica Ag
Publication of IL56577A0 publication Critical patent/IL56577A0/xx
Publication of IL56577A publication Critical patent/IL56577A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
IL56577A 1978-02-10 1979-02-02 Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones IL56577A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140478 1978-02-10

Publications (2)

Publication Number Publication Date
IL56577A0 IL56577A0 (en) 1979-05-31
IL56577A true IL56577A (en) 1982-07-30

Family

ID=4209637

Family Applications (1)

Application Number Title Priority Date Filing Date
IL56577A IL56577A (en) 1978-02-10 1979-02-02 Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones

Country Status (12)

Country Link
US (2) US4239770A (fr)
EP (1) EP0003602B1 (fr)
JP (1) JPS54117469A (fr)
AU (1) AU525204B2 (fr)
CA (1) CA1115212A (fr)
DE (1) DE2967324D1 (fr)
IE (1) IE48897B1 (fr)
IL (1) IL56577A (fr)
MC (1) MC1258A1 (fr)
NZ (1) NZ189572A (fr)
PH (1) PH14270A (fr)
ZA (1) ZA79452B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1131959B (it) * 1979-08-09 1986-06-25 Hoffmann La Roche Derivati pirrolidinici
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4431662A (en) * 1981-03-06 1984-02-14 Hodgson Gordon L Jun 1-(1,3-Benzodioxol-5-yl)-2-pyrrolidinone and its medicinal use
JPS5965071A (ja) * 1982-09-02 1984-04-13 ザ・ウエルカム・フアウンデ−シヨン・リミテツド 鎮痛、抗炎症剤
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3706399A1 (de) * 1987-02-27 1988-09-08 Boehringer Ingelheim Kg Mittel mit antidepressiver wirkung
IT1215587B (it) * 1987-06-26 1990-02-14 Roussel Maestretti Spa Derivati della 1-benzoil2-oxo 5-alcossi pirrolidina, loro procedimento di preparazione e loro impiego come sostanza medicinale.
IT1231921B (it) * 1989-06-12 1992-01-15 Sigma Tau Ind Farmaceuti 1-acil-2-pirrolidoni quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
JP2803882B2 (ja) * 1990-02-20 1998-09-24 日清製粉株式会社 １―フエノキシカルボニル―２―ピロリジノン誘導体
IT1242043B (it) * 1990-12-21 1994-02-02 Sigma Tau Ind Farmaceuti Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono.
US5780375A (en) * 1993-10-19 1998-07-14 E. I. Du Pont De Nemours And Company Thick film composition for modifying the electrical properties of a dielectric layer
PL3068782T3 (pl) * 2013-11-13 2018-12-31 Vertex Pharmaceuticals Incorporated Sposoby wytwarzania inhibitorów replikacji wirusów grypy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2915430A (en) * 1958-09-30 1959-12-01 Gen Aniline & Film Corp Method of controlling nematodes with n-acylpyrrolidones
GB1039113A (en) 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
ES425600A1 (es) * 1974-04-23 1977-01-16 Lafarquim Procedimiento de obtencion de un nuevo derivado de pirroli- dinona.
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
ES433723A1 (es) * 1975-01-10 1976-11-16 Lafarquim S A Lab Procedimiento de obtencion de un derivado de 2-pirrolidi- nona.
DE2616374A1 (de) * 1976-04-14 1977-10-27 Bayer Ag In 4-stellung amidoalkylierte phenole

Also Published As

Publication number Publication date
NZ189572A (en) 1985-01-31
IE48897B1 (en) 1985-06-12
PH14270A (en) 1981-04-29
EP0003602B1 (fr) 1984-12-12
ZA79452B (en) 1980-02-27
US4349562A (en) 1982-09-14
AU525204B2 (en) 1982-10-28
MC1258A1 (fr) 1980-01-14
JPS54117469A (en) 1979-09-12
IL56577A0 (en) 1979-05-31
IE790245L (en) 1979-08-10
EP0003602A1 (fr) 1979-08-22
JPS6210206B2 (fr) 1987-03-05
CA1115212A (fr) 1981-12-29
US4239770A (en) 1980-12-16
DE2967324D1 (en) 1985-01-24
AU4388979A (en) 1979-08-16

Similar Documents

Publication Publication Date Title
GB2039738B (en) Inflammation - preventing pharmaceutical composition
JPS54132223A (en) Novel pharmaceutical composition
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
NZ194421A (en) 3-amino-sydnone-imines pharmaceutical compositions
ZA787000B (en) Pharmaceutical formulation
NZ189939A (en) N-oxacyclic-alkylpiperidyl-diaza compounds pharmaceutical compositions
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
IL56577A (en) Pharmaceutical compositions comprising certain 1-substituted-2-pyrrolidinones
ZA79395B (en) Pharmaceutical formulations
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
GB2011785B (en) Coated pharmaceutical compositions
GB2034587B (en) Pharmaceutical compositions
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
JPS54154516A (en) Pharmaceutical composition
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
NZ190293A (en) Benzimidoyl-piperazines and pharmaceutical compositions
JPS5527168A (en) Drug composition
NZ193533A (en) 2-isopropylamino-5-halogeno-pyrimidines pharmaceutical compositions
IL57882A0 (en) 2-thiophenecarboxamido-alkylmercaptans and pharmaceutical compositions containing them
ZA794484B (en) Pharmaceutical compositions
AU523405B2 (en) Pharmaceutical compositions
ZA791032B (en) Pharmaceutical compositions